Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome
Li J, Zhang W, Jiao L, et al.
Eur J Haematol · 2015
Grade Ccohortn=12
Key Findings
- ●Overall hematologic response 77%, complete response 44%
- ●Neurological response 67%
- ●VEGF response 91%
Referenced in (1 disease)
ID: pmid-25401269DOI: 10.1111/ejh.12479PMID: 25401269